Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition
Advanced Science · 2025
DOI: 10.1002/advs.202407236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Mingyu Park und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea. Hauptthemen laut MEDLINE: Autophagy, Photosensitizing Agents, Drug Resistance, Neoplasm, Iridium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ulsan National Institute of Science and Technology, National Research Foundation of Korea, National Cancer Center.
Abstract (Originalsprache)
Autophagy is a crucial quality control mechanism that degrades damaged cellular components through lysosomal fusion with autophagosomes. However, elevated autophagy levels can promote drug resistance in cancer cells, enhancing their survival. Downregulation of autophagy through oxidative stress is a clinically promising strategy to counteract drug resistance, yet precise control of oxidative stress in autophagic proteins remains challenging. Here, a molecular design strategy of biocompatible neutral Ir(III) photosensitizers is demonstrated, B2 and B4, for precise reactive oxygen species (ROS) control at lysosomes to inhibit autophagy. The underlying molecular mechanisms for the biocompatibility and lysosome selectivity of Ir(III) complexes are explored by comparing B2 with the cationic or the non‐lysosome‐targeting analogs. Also, the biological mechanisms for autophagy inhibition via lysosomal oxidation are explored. Proteome analyses reveal significant oxidation of proteins essential for autophagy, including lysosomal and fusion‐mediator proteins. These findings are verified in vitro, using mass spectrometry, live cell imaging, and a model SNARE complex. The anti‐tumor efficacy of the precise lysosomal oxidation strategy is further validated in vivo with B4, engineered for red light absorbance. This study is expected to inspire the therapeutic use of spatiotemporal ROS control for sophisticated modulation of autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.
- X-dynamic Research Center, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.
- Institute for Cancer Genetics, Department of Genetics and Development, Columbia University Medical Center, New York, NY, 10032, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
- Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk, 37673, Republic of Korea.
- Research Center, O2MEDi inc., Ulsan, 44919, Republic of Korea.
ORCID-Profile: Jung Seung Nam, Tae-Hyuk Kwon
Förderung
- Ulsan National Institute of Science and Technology
- National Research Foundation of Korea
- National Cancer Center
- Korea Technology & Information Promotion Agency for SMEs
- Korea Innovation Foundation
Zitieren
APA
Park, M., Nam, J. S., Kim, T., Yoon, G., Kim, S., Lee, C., Lee, C. G., Park, S., Bejoymohandas, K. S., Yang, J., Kwon, Y. H., Lee, Y. J., Seo, J. K., Min, D., Park, T., & Kwon, T. H. (2025). Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition. Advanced Science. https://doi.org/10.1002/advs.202407236
Vancouver
Park M, Nam JS, Kim T, Yoon G, Kim S, Lee C, et al. Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition. Advanced Science. 2025. doi:10.1002/advs.202407236
BibTeX
@article{Park2025,
author = {Park, Mingyu and Nam, Jung Seung and Kim, Taehyun and Yoon, Gwangsu and Kim, Seoyoon and Lee, Chaiheon and Lee, Chae Gyu and Park, Sungjin and Bejoymohandas, Kochan S and Yang, Jihyeon and Kwon, Yoon Hee and Lee, Yoo Jin and Seo, Jeong Kon and Min, Duyoung and Park, Taiho and Kwon, Tae-Hyuk},
title = {Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202407236}
}
EUVIMED